Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Safety Study of CB-03-01 Cream in Healthy Volunteers
jRCT2071230110Completed
- Sponsor
- Sun Pharma
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of clascoterone in acne vulgaris, sponsored by Sun Pharma. Primary endpoints: Skin safety and irritation, Adverse events and 2 more. Started Feb 2024; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2071230110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230110.